Shares of Medtronic (MDT) traded marginally lower on Thursday after rising from a low of $80.01 from the past six trading sessions, where shares soared overall ...
Medtronic plc (NYSE:MDT) develops, manufactures and sells device-based medical therapies to health care systems, physicians, clinicians and patients worldwide. It will report its Q3 2025 earnings on ...
In a report released today, Richard Newitter from Truist Financial maintained a Hold rating on Medtronic (MDT – Research Report). The company’s ...
Medtronic said the Centers for Medicare & Medicaid Services is opening a coverage analysis on renal denervation for patients with hypertension that will include the review of its medical device. The ...